Prostate Cancer Reports

Volume 6 Number 11
November 2018


Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 10, November



CONTENTS


CASE REPORTS
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
PROGNOSIS
TREATMENT





CASE REPORTS

.

Omidele OO, Schiff HI, Oh W, Tewari A.
Multimodal therapy in the treatment of metastatic prostate cancer: A case report.
Urol Case Rep. 2018 Sep 19;21:92-94. doi: 10.1016/j.eucr.2018.09.010. eCollection 2018 Nov.
Source | Full text | Similar articles



.

van Kalmthout L, Stam A, Gans R, Lam M.
Visual deficit possibly caused by lutetium-177 PSMA treatment.
BMJ Case Rep. 2018 Oct 8;2018. pii: bcr-2018-225508. doi: 10.1136/bcr-2018-225508.
Source | Abstract | Similar articles



DIAGNOSIS

.

Beck V, Schlenker B, Herlemann A, Apfelbeck M, Buchner A, Gratzke C, Stief CG, Tritschler S.
The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade.
World J Urol. 2018 Sep 17. doi: 10.1007/s00345-018-2487-0. [Epub ahead of print]
Source | Full text | Similar articles



.

Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, Sooriakumaran P, Verrill CL, Gleeson F, MacPherson R, Hamdy FC, Brewster SF.
Comparison of prostate biopsy with or without pre-biopsy multi-parametric MRI in prostate cancer detection: an observational cohort study.
J Urol. 2018 Sep 25. pii: S0022-5347(18)43943-2. doi: 10.1016/j.juro.2018.09.049. [Epub ahead of print]
Source | Abstract | Similar articles



.

Civelek AC.
68Ga-PSMA-11 PET: Better at Detecting Prostate Cancer than Multiparametric MRI?
Radiology. 2018 Sep 18:181981. doi: 10.1148/radiol.2018181981. [Epub ahead of print]
Comment on: Hicks RM et al, Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. [Radiology. 2018 Sep 18].
Source | Full text | Similar articles



.

Donato P, Roberts MJ, Morton A, Kyle S, Coughlin G, Esler R, Dunglison N, Gardiner RA, Yaxley J.
Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology.
Eur J Nucl Med Mol Imaging. 2018 Sep 19. doi: 10.1007/s00259-018-4160-7. [Epub ahead of print]
Source | Full text | Similar articles



.

Ergül N, Yilmaz Güneş B, Yücetaş U, Toktaş MG, Çermik TF.
68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
Clin Nucl Med. 2018 Sep 28. doi: 10.1097/RLU.0000000000002289. [Epub ahead of print]
Source | Abstract | Similar articles



.

Gumulec J, Raudenska M, Pacik D, Plevova M, Sorokac-Kubolkova A, Lackova Z, Cernei N, Strmiska V, Zitka O, Heger Z, Adam V.
Post-treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer.
Cancer Med. 2018 Sep 12. doi: 10.1002/cam4.1767. [Epub ahead of print]
Source | Full text | Similar articles



.

Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA.
Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.
Radiology. 2018 Sep 18:180788. doi: 10.1148/radiol.2018180788. [Epub ahead of print]
Source | Abstract | Similar articles



.

Kaye DR, Qi J, Morgan TM, Linsell S, Ginsburg KB, Lane BR, Montie JE, Cher ML, Miller DC; Michigan Urological Surgery Improvement Collaborative.
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
BJU Int. 2018 Sep 24. doi: 10.1111/bju.14554. [Epub ahead of print]
Source | Full text | Similar articles



.

Oderda M, Joniau S, Palazzetti A, Falcone M, Melloni G, Van Den Bossche H, Deconinck S, Zattoni F, Karnes RJ, Gontero P.
Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
Eur Urol Focus. 2018 Mar;4(2):288-293. doi: 10.1016/j.euf.2015.12.004. Epub 2016 Oct 17.
Source | Full text | Similar articles



.

Pinsky PF, Miller E, Prorok P, Grubb R, Crawford ED, Andriole G.
Extended follow-up for prostate cancer incidence and mortality in the PLCO randomized cancer screening trial.
BJU Int. 2018 Oct 5. doi: 10.1111/bju.14580. [Epub ahead of print]
Source | Full text | Similar articles



.

Shinde A, Li R, Glaser S, Amini A.
Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging?
Eur Urol. 2018 Sep 24. pii: S0302-2838(18)30667-5. doi: 10.1016/j.eururo.2018.09.017. [Epub ahead of print]
Source | Full text | Similar articles



.

Winoker JS, Pinto PA, Rastinehad AR.
MRI to guide biopsies or avoid biopsies?
Curr Opin Urol. 2018 Nov;28(6):522-528. doi: 10.1097/MOU.0000000000000555.
Source | Abstract | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION



.

Lu DL, Ren ZJ, Zhang Q, Ren PW, Yang B, Liu LR, Dong Q.
Meta-analysis of the association between the inflammatory potential of diet and urologic cancer risk.
PLoS One. 2018 Oct 1;13(10):e0204845. doi: 10.1371/journal.pone.0204845. eCollection 2018.
Source | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY

.

Choi YJ, Lee DH, Han KD, Yoon H, Shin CM, Park YS, Kim N.
Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.
PLoS One. 2018 Sep 19;13(9):e0201308. doi: 10.1371/journal.pone.0201308. eCollection 2018.
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30722-X. doi: 10.1016/j.eururo.2018.09.034. [Epub ahead of print]
Source | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Schneider L, Su LJ, Arab L, Bensen JT, Farnan L, Fontham ETH, Song L, Hussey J, Merchant AT, Mohler JL, Steck SE.
Dietary patterns based on the Mediterranean diet and DASH diet are inversely associated with high aggressive prostate cancer in PCaP.
Ann Epidemiol. 2018 Sep 5. pii: S1047-2797(18)30283-7. doi: 10.1016/j.annepidem.2018.08.012. [Epub ahead of print]
Source | Full text | Similar articles



PROGNOSIS

.

Chow K, Herrera P, Stuchbery R, Peters JS, Costello AJ, Hovens CM, Corcoran NM.
Late Biochemical Recurrence Post-Prostatectomy is Associated with a Slower Rate of Progression.
BJU Int. 2018 Sep 24. doi: 10.1111/bju.14556. [Epub ahead of print]
Source | Full text | Similar articles



.

Kirmiz S, Qi J, Babitz SK, Linsell S, Denton B, Singh K, Auffenberg G, Montie JE, Lane BR.
Grade Groups Provides Improved Predictions of Pathologic and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.
J Urol. 2018 Sep 6. pii: S0022-5347(18)43836-0. doi: 10.1016/j.juro.2018.08.081. [Epub ahead of print]
Source | Abstract | Similar articles



.

Loeb S, Folkvaljon Y, Bratt O, Robinson D, Stattin P.
Defining Intermediate-Risk Prostate Cancer Suitable for Active Surveillance.
J Urol. 2018 Sep 18. pii: S0022-5347(18)43908-0. doi: 10.1016/j.juro.2018.09.042. [Epub ahead of print]
Source | Abstract | Similar articles



.

Patel DN, Jha S, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Chapin BF, Freedland SJ.
Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
Int J Urol. 2018 Sep 25. doi: 10.1111/iju.13806. [Epub ahead of print]
Source | Full text | Similar articles



.

Tsang SH, Peisch SF, Rowan B, Markt SC, Gonzalez-Feliciano AG, Sutcliffe S, Platz EA, Mucci LA, Ebot EM.
Association between Trichomonas vaginalis and prostate cancer mortality.
Int J Cancer. 2018 Sep 22. doi: 10.1002/ijc.31885. [Epub ahead of print]
Source | Full text | Similar articles



.

Wu S, Lin SX, Wirth GJ, Lu M, Lu J, Subtelny AO, Wang Z, Dahl DM, Olumi AF, Wu CL.
Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome.
Clin Genitourin Cancer. 2018 Aug 30. pii: S1558-7673(18)30522-6. doi: 10.1016/j.clgc.2018.08.007. [Epub ahead of print]
Source | Full text | Similar articles



TREATMENT

.

Cunningham JJ, Brown JS, Gatenby RA, Staňková K.
Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer.
J Theor Biol. 2018 Sep 20;459:67-78. doi: 10.1016/j.jtbi.2018.09.022. [Epub ahead of print]
Source | Full text | Similar articles



.

Delouya G, Taussky D.
Pelvic radiotherapy in prostate cancer: an unresolved question.
Lancet Oncol. 2018 Oct 10. pii: S1470-2045(18)30588-6. doi: 10.1016/S1470-2045(18)30588-6. [Epub ahead of print]
Comment on: Roach M et al, Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. [Lancet Oncol. 2018 Oct 10]
Source | Full text | Similar articles



.

Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, Van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A.
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
Eur Urol. 2018 Oct 6. pii: S0302-2838(18)30659-6. doi: 10.1016/j.eururo.2018.09.009. [Epub ahead of print]
Source | Full text | Similar articles



.

Loi M, Di Cataldo V, Francolini G, Bonomo P, Masi L, Simontacchi G, Detti B, Greto D, Desideri I, Livi L.
Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer.
Oncol Res Treat. 2018 Oct 13;41(11). doi: 10.1159/000491605. [Epub ahead of print]
Source | Abstract | Similar articles



.

Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM.
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Lancet Oncol. 2018 Oct 10. pii: S1470-2045(18)30528-X. doi: 10.1016/S1470-2045(18)30528-X. [Epub ahead of print]
Source | Full text | Similar articles



.

Soldatov A, von Klot CAJ, Walacides D, Derlin T, Bengel FM, Ross TL, Wester HJ, Derlin K, Kuczyk MA, Christiansen H, Henkenberens C.
Patterns of progression after 68Ga-PSMA-ligand PET/CT-guided radiotherapy for recurrent prostate cancer.
Int J Radiat Oncol Biol Phys. 2018 Sep 7. pii: S0360-3016(18)33708-8. doi: 10.1016/j.ijrobp.2018.08.066. [Epub ahead of print]
Source | Abstract | Similar articles





bottom